NPI: 1215332945 · RIVERSIDE, CA 92505 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/23/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/23/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,369 | $237K |
| 2019 | 32,218 | $1.75M |
| 2020 | 28,919 | $1.73M |
| 2021 | 28,390 | $1.59M |
| 2022 | 31,945 | $1.50M |
| 2023 | 38,254 | $2.17M |
| 2024 | 26,288 | $2.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90945 | 138,196 | 4,753 | $10.26M | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,276 | 719 | $635K |
| A4657 | Syringe, with or without needle, each | 2,078 | 2,034 | $64K |
| 82728 | 3,078 | 3,007 | $27K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 10,239 | 3,274 | $23K |
| 0250 | 2,345 | 1,115 | $22K | |
| 90993 | 83 | 30 | $19K | |
| 82570 | 1,549 | 711 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 246 | 246 | $2K |
| 83540 | 3,086 | 3,012 | $752.68 | |
| 90661 | 22 | 22 | $678.04 | |
| 85048 | 3,084 | 3,001 | $34.18 | |
| 83970 | 3,079 | 3,002 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 3,481 | 2,877 | $0.00 |
| 85041 | 3,090 | 3,008 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 549 | 500 | $0.00 |
| 83550 | 2,472 | 2,400 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 85 | 83 | $0.00 |
| 84540 | 439 | 372 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 692 | 537 | $0.00 |
| 90674 | 181 | 172 | $0.00 | |
| 90747 | 13 | 13 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 20 | 13 | $0.00 |